Asensus Surgical Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2024 to a ratio of 6.3, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2024. Average receivable collection period, for the Asensus Surgical Inc in Jun 30 2024 quarter, has decreased to 58 days, compared to 65 days, in the Mar 31 2024 quarter.

If we take a look into Healthcare sector 520 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2024 from 2762 to 3367.

What is Receivable Turnover Ratio?
What is Asensus Surgical Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ASXC Receivables Turnover Ratio	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Receivable Change	-38.48 %	2.58 %	55.5 %	-70.58 %	-5.58 %
Y / Y Revenue Change	53.72 %	9.32 %	120.41 %	-91.42 %	1.31 %
Receivable Turnover Ratio (TTM)	6.3	5.61	5.56	4.41	4.81
ASXC's Total Ranking	# 3367	# 2762	# 3387	# 2056	#
Accounts Receivable average collection period days	58	65	66	83	76
Seq. Receivable Change	-39.85 %	-80.76 %	429.91 %	0.3 %	0.3 %
Seq. Revenue Change	45.08 %	-80.35 %	2368.64 %	-78.15 %	3.18 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 176
Healthcare Sector	# 521
Overall Market	# 3367

Receivable Turnover Ratio Statistics
High	Average	Low
0.1	0.05	0
(Dec 31 2018)		(Dec 31 2014)

ASXC Company Profile • Back to ASXC Efficiency Comparisons • Compare ASXC Receivables Turnover Ratio to its Competitors

Financial Statements
Asensus Surgical Inc 's Accounts Receivable	$ 0 Millions	Visit ASXC's Balance sheet
Asensus Surgical Inc 's Sales TTM	$ 8 Millions	Visit ASXC's Income Statement
Sources of ASXC's Revenues		Visit ASXC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ASXC's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ASXC's Growth Rates	ASXC's Roa	ASXC's Inventory Turnover Ratio	ASXC's Dividend Comparisons
ASXC's Profitability Ratios	ASXC's Roi	ASXC's Asset Turnover Ratio	ASXC's Dividend Growth
ASXC's Valuation Ratios	ASXC's Roe	ASXC's Financial Strength Ratios	ASXC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2024	Receivable at quarter ending Jun 30 2024
Cervomed Inc	55.85	$ 12.781 Millions	$ 0.229 Millions
Lucid Diagnostics Inc	55.27	$ 3.800 Millions	$ 0.069 Millions
Agape Atp Corporation	52.58	$ 1.378 Millions	$ 0.026 Millions
Nektar Therapeutics	45.32	$ 93.157 Millions	$ 2.056 Millions
Nature s Sunshine Products inc	44.96	$ 441.734 Millions	$ 9.826 Millions
Pavmed Inc	44.20	$ 4.232 Millions	$ 0.096 Millions
Xoma Royalty Corporation	38.68	$ 15.239 Millions	$ 0.394 Millions
Vivos Therapeutics Inc	38.23	$ 12.904 Millions	$ 0.338 Millions
Adaptimmune Therapeutics Plc	35.77	$ 141.459 Millions	$ 3.954 Millions
Eyepoint Inc	35.50	$ 50.391 Millions	$ 1.420 Millions
Electrocore Inc	35.32	$ 20.477 Millions	$ 0.580 Millions
Lifemd Inc	34.18	$ 176.873 Millions	$ 5.175 Millions
Invo Fertility Inc	33.38	$ 5.770 Millions	$ 0.173 Millions
Spero Therapeutics Inc	33.17	$ 118.460 Millions	$ 3.571 Millions
23andme Holding Co	32.93	$ 198.211 Millions	$ 6.020 Millions
Ontrak Inc	32.71	$ 11.442 Millions	$ 0.350 Millions
Marpai Inc	30.74	$ 31.814 Millions	$ 1.035 Millions
Sonida Senior Living Inc	30.09	$ 268.040 Millions	$ 8.908 Millions
Clearside Biomedical Inc	28.61	$ 7.524 Millions	$ 0.263 Millions
National Vision Holdings Inc	27.21	$ 2,033.015 Millions	$ 74.709 Millions
Cv Sciences Inc	26.63	$ 14.932 Millions	$ 0.561 Millions
Sab Biotherapeutics Inc	26.59	$ 2.780 Millions	$ 0.105 Millions
Orchestra Biomed Holdings Inc	25.05	$ 2.079 Millions	$ 0.083 Millions
Kymera Therapeutics Inc	23.61	$ 88.550 Millions	$ 3.750 Millions
Renalytix Plc	22.89	$ 2.289 Millions	$ 0.100 Millions
Agenus Inc	22.75	$ 159.630 Millions	$ 7.015 Millions
Kiniksa Pharmaceuticals International Plc	22.32	$ 338.930 Millions	$ 15.188 Millions
U S Physical Therapy Inc	22.07	$ 627.673 Millions	$ 28.444 Millions
Cytomx Therapeutics Inc	21.94	$ 119.569 Millions	$ 5.451 Millions
Vireo Growth Inc.	21.79	$ 98.044 Millions	$ 4.500 Millions

Date modified: 2026-08-29T17:23:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.